Cuprizone induced-demyelination in mice alters brain expression of genes involved in arachidonic acid metabolism . by Bosetti F. et al.
However, the molecular mechanism underlying the down-
regulation of Foxp3 is not understood yet. Because IL-12p40
homodimer (p40-2) is markedly up-regulated in response to
various inflammatory stimuli, the present study was under-
taken to explore the role of p402 in the regulation of Foxp3 in
naı¨ve mouse splenocytes. IL-12p40-2 dose-dependently inhib-
ited the expression of Foxp3 and CD25, but not CD4.
Interestingly, this inhibition was absent in splenocytes of
IL-12Rb1 (ÿ/ÿ), but not IL-12Rb2 (ÿ/ÿ), mice. Moreover,
suppression of Foxp3 in wild type and IL-12Rb2 (ÿ/ÿ)
splenocytes was accompanied by production of NO. Consis-
tently, L-NIL, an inhibitor of iNOS, and PTIO, a scavenger of
NO, restored the expression of Foxp3 and CD25 in p40-2-
stimulated splenocytes and p40-2 was unable to down-regulate
Foxp3 and CD25 in splenocytes from iNOS(ÿ/ÿ) mice.
Furthermore, NO, but not p40-2, was able to inhibit Foxp3
in purified CD41CD251T cells in the absence of iNOS-
expressing cells. Hence, our results clearly demonstrate that
p40-2 induces NO production via IL-12Rb1 and that NO
subsequently suppresses Tregs in naı¨ve mouse splenocytes. This
study, therefore, delineates an unprecedented biological func-
tion of p40-2 in the regulation of Foxp3 via IL-12Rb1-
mediated NO production. Supported by grants from NIH
(NS39940 and NS48923).
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Chronic feeding with the copper chelator cuprizone in mice
causes oligodendrocyte death and subsequent reversible
demyelination. Although the mechanism of demyelination is
unknown, activation of glia is integral to the process. Since
metabolism of arachidonic acid (AA) is involved in glial
activation, we hypothesized that cuprizone exposure would
alter expression of AA cascade genes. Mice were fed 0.2 %
cuprizone in the diet for 6 weeks and then returned to a normal
diet. Histochemistry with the myelin stains Black Gold and
Fluoromyelin demonstrated that frank demyelination and
influx of glial cells into the corpus collosum begins at week 3
and peaks at week 5. A decrease in myelin and oligodendrocyte
markers, accompanied by increased expression of markers of
microglia (CD11b) and astrocytes (glial acidic fibrillary
protein), was evident at week one. Gene expression of
cyclooxygenase-2 and 15-lipoxygenase (LOX) was also chan-
ged at week one, suggesting that these genes are either involved
in or respond to early demyelination. Expression of 5-LOX was
not changed during early demyelination but it peaked during
week 5, when glial markers and frank demyelination also
reached their peak, suggesting that 5-LOX expression is a
consequence of the massive influx of inflammatory cells into
the area of demyelination. Our study is the first to demonstrate
that multiple enzymes involved in arachidonic acid metabolism
are altered in the cuprizone model of demyelination and
remyelination. These data may help to develop new therapeutic
targets to treat human demyelinating diseases, such as multiple
sclerosis.
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Multiple sclerosis (MS) is an autoimmune disease of the CNS.
MS has both immune and neurodegenerative arms. Adoptive
transfer (AT) of myelin basic protein (MBP)-specific T cells
into naı¨ve SJL/J mice results in a relapsing-remitting (RR)
form of experimental autoimmune encephalomyelitis (EAE)
that mimics the RR subtype in 85% of MS patients. Blocking
mechanisms by which MBP-specific T cells are activated to
induce disease may help dissect immune arm of the disease and
offer novel targets for therapy. One such target is calpain since
calpain is involved in T cell activation, migration of immune
cells into the CNS, and degradation of axonal and myelin
proteins. We tested the hypothesis that incubating MBP-
specific T cells with the calpain inhibitor SJA6017 before AT
would diminish ability of these T cells to elicit inflammatory
response. EAE mice that received MBP-specific T cells
incubated without SJA6017 (ES-0) developed classic symptoms
of disease, while EAE mice that received MBP-specific T cells
incubated with 10 to 100 mM SJA6017 (ES-10 to ES-100)
exhibited dose-dependent reduction in clinical symptoms and
relapse rate. These reductions correlated with decreases in
demyelination, inflammation, axonal damage, and loss of
neurons and oligodendrocytes. DNA laddering, calpain:cal-
pastatin and Bax:Bcl-2 ratios, tBid production, and activities of
calpain and caspases. Thus, these data further suggest calpain
as a target for treating EAE and MS. This study was supported
in part by the R01 grants from the NINDS.
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